Jonathan S. Nguyen-Van-Tam

University of Nottingham - Division of Epidemiology and Public Health

University Park

Nottingham, NG8 1BB

United Kingdom

SCHOLARLY PAPERS

4

DOWNLOADS
Rank 1,244

SSRN RANKINGS

Top 1,244

in Total Papers Downloads

32,561

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (4)

1.

Safety and Immunogenicity Report from the Com-COV Study – a Single-Blind Randomised Non-Inferiority Trial Comparing Heterologous And Homologous Prime-Boost Schedules with An Adenoviral Vectored and mRNA COVID-19 Vaccine

Number of pages: 45 Posted: 25 Jun 2021
University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford - Oxford Vaccine Group, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, Public Health England Colindale, Government of the United Kingdom - Public Health Scotland, Liverpool School of Tropical Medicine - Department of Clinical Sciences, Liverpool School of Tropical Medicine - Department of Clinical Sciences, Liverpool School of Tropical Medicine - Department of Clinical Sciences, University Hospitals Birmingham NHS Foundation Trust, Public Health England - National Infection Service, University of London - Institute of Infection and Immunity, University of Southampton - NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University of Bristol - Bristol Vaccine Centre, University of Oxford - The Jenner Institute, Government of the United Kingdom - North Bristol NHS Trust, NIHR UCLH Clinical Research Facility, Public Health England - Immunisation, Hepatitis, and Blood Safety Department, University of Southampton - University Hospital Southampton NHS Foundation Trust, Nottingham University Hospitals NHS Trust, Imperial College London - National Heart & Lung Institute, University of Nottingham - Division of Epidemiology and Public Health, University of Oxford - Centre for Vaccinology and Tropical Medicine and Independent
Downloads 25,134 (142)
Citation 4

Abstract:

Loading...

2.

Molnupiravir Plus Usual Care Versus Usual Care Alone as Early Treatment for Adults with COVID-19 at Increased Risk of Adverse Outcomes (PANORAMIC): Preliminary Analysis from the United Kingdom Randomised, Controlled Open-Label, Platform Adaptive Trial

Number of pages: 43 Posted: 17 Oct 2022
University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Oxford Respiratory Trials Unit, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford - Nuffield Department of Primary Care Health Sciences, University College London - UCL Institute of Immunity and Transplantation, University College London - Department of Infection, Inflammation and Immunity, University College London - Department of Infection, Inflammation and Immunity, University of Liverpool - Department of Pharmacology, University of Oxford - Nuffield Department of Primary Care Health Sciences, Cardiff University - Centre for Trials Research, University of Nottingham - Division of Epidemiology and Public Health, University of Oxford - Nuffield Department of Primary Care Health Sciences, Berry Consultants, LLC, Berry Consultants, LLC, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Southampton - Primary Care Research Centre, Windrush Medical Practice, University of Exeter - Faculty of Health and Life Sciences, University of Oxford - Oxford Respiratory Trials Unit, Cardiff University - Centre for Trials Research, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Southampton - Primary Care Research Centre, University of Oxford - Nuffield Department of Primary Care Health Sciences, Berry Consultants, LLC, Berry Consultants, LLC, Berry Consultants, LLC, Berry Consultants, LLC, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Glasgow - Institute of Health and Wellbeing, Queen's University Belfast - School of Medicine, Dentistry & Biomedical Science, Queen's University Belfast - School of Medicine, Dentistry & Biomedical Science, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Primary Care Health Sciences, NHS Foundation Trust - Oxford University Hospitals, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Primary Care Health Sciences, North Manchester General Hospital - Regional Infectious Diseases Unit, Cardiff University - Centre for Trials Research, University of Oxford - Nuffield Department of Primary Care Health Sciences and University of Southampton - Primary Care and Population Science
Downloads 4,196 (3,527)

Abstract:

Loading...

COVID-19, clincial trial, antiviral agents, primary health care, molnupiravir

3.

The Safety and Immunogenicity of Concomitant Administration of COVID-19 Vaccines (ChAdOx1 or BNT162b2) with Seasonal Influenza Vaccines in Adults: A Phase IV, Multicentre Randomised Controlled Trial with Blinding (ComFluCOV)

Number of pages: 36 Posted: 30 Sep 2021
University Hospitals Bristol - University Hospitals Bristol and Weston NHS Foundation Trust, University of Bristol, University Hospitals Bristol, Cardiff University - Centre for Trials Research, University of Bristol - Bristol Vaccine Centre, University Hospitals Bristol, Government of the United Kingdom - Royal United Hospitals Bath NHS Foundation Trust, Government of the United Kingdom - National Health Service (NHS), Government of the United Kingdom - Royal United Hospitals Bath NHS Foundation Trust, Public Health England - National Infection Service, University of Bristol, University of Bristol, University of Bristol, University of Bristol, National Health Service, United Kingdom, NIHR UCLH Clinical Research Facility, University Hospitals Bristol - University Hospitals Bristol and Weston NHS Foundation Trust, University Hospitals Bristol - University Hospitals Bristol NHS Foundation Trust, Government of the United Kingdom - National Health Service (NHS), Government of the United Kingdom - National Health Service (NHS), Government of the United Kingdom - Great Western Hospitals, The Alverton Practice, University of Bristol, University of Bristol, University of Oxford - Centre for Vaccinology and Tropical Medicine, Government of the United Kingdom - National Health Service (NHS), Government of the United Kingdom - National Health Service (NHS), University of Nottingham - Division of Epidemiology and Public Health, University of Bristol - Bristol Vaccine Centre, University of Bristol and Independent
Downloads 3,146 (5,756)

Abstract:

Loading...

Concomitant vaccination, COVID-19 vaccine, Influenza vaccine, Clinical Trial

4.

Co-Infections, Secondary Infections, and Antimicrobial Usage in Hospitalised Patients with COVID-19 from the ISARIC WHO CCP-UK Study: A Prospective, Multicentre Cohort Study

Number of pages: 22 Posted: 16 Feb 2021
University of Edinburgh - Centre for Inflammation Research, University of Edinburgh - Centre for Medical Informatics, University of Edinburgh - Centre for Medical Informatics, University of Liverpool - NIHR Health Protection Research Unit for Emerging and Zoonotic Infection, Queen Elizabeth University Hospital, University of Liverpool - Institute of Infection, Veterinary and Ecological Sciences, University of Oxford - International Severe Acute Respiratory and Emerging Infections Consortium (ISARIC), University of Edinburgh - Centre for Medical Informatics, University of Edinburgh - Centre for Medical Informatics, University of Sheffield - The Florey Institute for Host-Pathogen Interactions, University of Edinburgh - Centre for Medical Informatics, University of Edinburgh - Centre for Medical Informatics, University of Liverpool - Institute of Infection, Veterinary and Ecological Sciences, University of Oxford - ISARIC Global Support Centre, University of Liverpool - Liverpool Clinical Trials Centre, Public Health England - Emerging Infections and Zoonoses Unit, University of Nottingham - Division of Epidemiology and Public Health, Imperial College London - National Heart and Lung Institute, University of Edinburgh - Roslin Institute, University of Liverpool - Health Protection Research Unit in Emerging and Zoonotic Infections, University of Glasgow - MRC-University of Glasgow Centre for Virus Research and Independent
Downloads 85 (420,267)

Abstract:

Loading...

co-infection; secondary infection; bacteria; antimicrobial; SARS-CoV-2; COVID-19